The Go-To CDMO for Your Most Challenging Biological Drug Product

The experience, capacity, and determination to go the distance

Fast Facts: Emergent's CDMO Division

Technologies

Traditional & Emerging: Mammalian, viral, microbial, plasma protein
Next-Gen Therapies: mRNA, viral vector and nanoparticle platforms, and oncolytic virus

Global Development & Manufacturing Sites

9

Industries Served

Emerging and virtual pharma and biotechs
Established small, mid-sized, and large pharma 
Government lab
Non-government research organizations

Scope of Services

Full molecule-to-market biologics manufacturing and scale-up support, including development services, drug substance and drug product/packaging, analytical and quality testing services

Product Lifestyle Support

All phases — Pre-clinical development through commercialization

Let’s Start A Conversation

Connect now